What is Artiva Biotherapeutics, Inc.'s debt-to-equity?

Artiva Biotherapeutics, Inc. (ARTV) reported debt-to-equity of 0.1× in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s debt-to-equity changed year-over-year?

Artiva Biotherapeutics, Inc.'s debt-to-equity increased by 40.9% year-over-year, from 0.1× to 0.1×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

Artiva Biotherapeutics, Inc. ARTV Debt-to-equity

Debt-to-equity at other companies

Bristol-Myers SquibbBMY

2.2×-0.6×

Gilead SciencesGILD

0.9×-0.4×

Kyverna Therapeutics, Inc.KYTX

0×0.0×

Allogene TherapeuticsALLO

0.3×+0.1×

Immix Biopharma, Inc.IMMX

0×-0.1×

Cullinan Therapeutics, Inc.CGEM

0×0.0×

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Current ratio8.2×-5.8×

Where this comes from

Calculated from Artiva Biotherapeutics, Inc.’s reported figures.

total debt/total stockholders equity=0.1×

Based on the most recent quarter.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s debt-to-equity?: Artiva Biotherapeutics, Inc. (ARTV) reported debt-to-equity of 0.1× in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s debt-to-equity changed year-over-year?: Artiva Biotherapeutics, Inc.'s debt-to-equity increased by 40.9% year-over-year, from 0.1× to 0.1×.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.